newsfilter
← Interviews
Milken Institute19 min

Centers for Disease Control and Prevention Director Erica Schwartz | Future of Health Summit 2026

Erica Schwartz, Jessica Nix

Interview, Fireside Chat
  • Measles Elimination Status and Outbreak Dynamics

    • Losing elimination status depends on the duration of an outbreak, not case volume; status is at risk if an outbreak persists longer than 12 months.
    • The Pan American Health Organization is reviewing US measles outbreaks to determine if endemic transmission has been established.
    • The CDC has allocated over $100 million to state partners since the outbreak began to support vaccination, laboratory sequencing, and surveillance.
    • Current case demographics show 17% of patients are under five, 42% are aged 5–19, and 41–42% are adults over 19.
    • Transmission is concentrated in close-knit communities with low vaccination rates, including adults who relied on decisions made decades prior.
    • Prevention strategies prioritize MMR vaccination for eligible populations, with specific isolation guidance for those who are pregnant or under one year of age and cannot be vaccinated.
    • The CDC is deploying "casting" surveillance to help states identify local outbreaks with limited data, emphasizing that state agencies must lead engagement as trusted community agents.
  • Restoring Institutional Trust (Internal and External)

    • CDC Director Dr. Mandy Schwartz identifies restoring trust with both the American public and CDC staff as a primary priority.
    • Internal psychological safety at the CDC is described as being at an all-time low due to recent staffing changes and the October 2023 shooting of Officer Stone.
    • To rebuild internal stability, the CDC is hiring permanent leadership for Chief Information Officer (CIO) roles and implementing a strategic 2027 hiring plan developed with staff input.
    • External trust rebuilding efforts focus on scientific transparency and a shift from authoritative mandates to humble, two-way public dialogue.
    • The Director plans to collaborate with the newly elected Congressional Doctors Caucus to find common ground on health policies despite partisan differences.
    • Innovation priorities for 2027 include "bio-threat radar," wastewater surveillance, and metagenomics, with specific mention of Senator Kim's visit regarding these tools.
  • Leadership Dynamics and Policy Conflicts

    • Dr. Schwartz meets daily with Secretary Robert Kennedy at 10:00 AM to discuss agency-wide issues alongside Dr. Bhattacharya, Dr. Oz, and FDA officials.
    • Leadership styles differ: Secretary Kennedy is described as highly decisive and inclusive of diverse opinions, whereas Dr. Schwartz describes herself as more indecisive and insular.
    • Disagreements with the Secretary occur regularly but are handled privately; decisions are made based on the weight of evidence, sometimes favoring the Director's view and sometimes not.
    • A specific disagreement occurred regarding the "340B issue," involving CDC, CMS, and HRSA, which the Secretary resolved after gathering all input.
    • Dr. Schwartz confirms she has never met with new Chief of Staff Stephen Miller.
    • Regarding the executive order on safer childhood vaccines, the task force report was due November 8th but remains in clearance; it will be submitted to the reconstituted Advisory Committee on Immunization Practices (ACIP).
    • The ACIP reconstitution is pending an appellate court ruling; a federal register notice for new members has been issued to prepare for immediate action if the court rules in favor.
  • Global Health and Respiratory Virus Trends

    • The CDC is responding to a deadly Ebola outbreak in the Democratic Republic of Congo (DRC) with a case fatality rate of 48%.
    • Response efforts in the DRC are hindered by regional disruption but have successfully improved contact tracing numbers from initially low levels to approximately 25 contacts per case.
    • The CDC and Africa CDC are providing daily support and monitoring the DRC's situation through the Emergency Operations Center.
    • Current US respiratory virus trends show rising influenza cases, but decreasing COVID-19 and RSV rates, with RSV currently at an all-time low.
    • A new surveillance tool, comparable to weather radar, allows the public to check zip-code-specific trends for influenza, COVID-19, and RSV to make informed healthcare decisions.